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Abstract
Background: Salvia libanotica (S. Libanotica) is a commonly used herb in folk medicine in Lebanon and the Middle
East. The present study aimed to assess the scientific basis for the therapeutic use of S. libanotica in glycemia and
to evaluate its effects on lipemia and abdominal fat.
Methods: Animals were fed a high-fat diet and allocated into a control and three experimental groups (GI, GII and
GIII) receiving incremental doses of the plant water extract in drinking water (50, 150 and 450 mg/Kg body weight
respectively) for six weeks.
Results: The intake of S. libanotica extract was associated with a significant decrease in fasting serum glucose
(102.9± 10.8 in GII and 87.5± 6.4 in GIII vs. 152.1± 7.9 mg/dl in controls) and a two fold increase in fasting serum
insulin (GIII) and liver glycogen content (GII and GIII). Group III also had better glucose tolerance following
intraperitoneal glucose challenges. Additionally, the plant extract intake produced a significant improvement in
serum HDL (34.4± 2.4 in GIII vs. 27.2± 1.9 mg/dl in controls) and HDL/LDL cholesterol ratio (2.79± 0.32 in GII and
3.02± 0.31 in GIII vs. 1.74± 0.18 in controls), as well as a decrease in abdominal fat.
Conclusion: The current study is the first to demonstrate that the chronic intake of S. libanotica infusion helps in
the prevention of high fat-induced hyperglycemia and dyslipidemia. This supports the plant use as a remedy for
the prevention of type 2 diabetes and cardiovascular diseases.
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Background
Diabetes and cardiovascular diseases are established as
serious public health problems around the globe and are
among the top five causes of death in most Western and
Arab countries [1, 2]. Insulin resistance, hyperglycemia
and dyslipidemia are common metabolic abnormalities
that could potentially lead to type 2 diabetes and cardio-
vascular diseases [3]. A very palatable diet that is widely
available nowadays is the high fat diet, rich in saturated
fats, which is known to contribute to insulin resistance
especially when it induces abdominal obesity [4]. This is
characterized by impaired insulin-stimulated glucose up-
take by peripheral tissues and subsequent hyperglycemia,
in addition to abnormalities in hepatic insulin signaling
leading to elevated blood lipids and gluconeogenesis and
lower glycogen and HDL levels [5]. While pharmaco-
logical treatments are widely prescribed to manage these
abnormalities, most are costly and have adverse side ef-
fects [6]. Thus, many patients and healthcare profes-
sionals are seeking alternative treatments by using
herbal remedies due to their potential effectiveness and
limited cost and toxicity [7].
Salvia libanotica (also named S. Fruiticosa and S. tri-
loba) of the “Lamiaceae” family is an aromatic medicinal
plant commonly known as East Mediterranean sage or
Lebanese sage [8]. In Lebanon, Syria and Jordan, the
plant is commercially available and widely used by the
elderly and folk medicine practitioners [9]. Its leaves are
usually used as infusion for the relief of headaches,
stomachaches, abdominal pain, hyperglycemia and many
other ailments [10–13].
In Lebanese folk medicine, S. libanotica is widely used
for its anti-diabetic properties in spite of the scarcity of
scientific evidence of its efficacy in the literature [9]. To
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our knowledge, only one study described the
hypoglycemic effects S. libanotica when using a 10 % in-
fusion of the plant leaves at an oral dose of 250 mg of
dry leaves/kg body weight in rabbits [14]. The proposed
mechanisms that were hypothesized by the authors in-
cluded a role of the plant in carbohydrate intestinal ab-
sorption and/or modification of hepatic metabolic
processes, since no effect was observed on plasma insu-
lin [14]. On the other hand, many studies have estab-
lished the hypoglycemic effect of leaves of the closely
related to Salvia officinalis (S. officinalis) species. Indeed,
S. officinalis methanolic extract was shown to signifi-
cantly decrease serum glucose in diabetic but not
healthy rats, with no effect on pancreatic insulin release
[15, 16]. Another study showed that water-ethanol ex-
tract of S. officinalis reduced blood glucose in normogly-
cemic and mildly alloxan-diabetic, but not in severely
alloxan-diabetic mice [17]. Additionally, replacing water
with S. officinalis infusion for 14 days resulted in lower
fasting plasma glucose with no effect on glucose clear-
ance in normal mice [18].
The effects of S. libanotica on blood lipemia have not
previously been studied. Yet, S. officinalis was shown to
have potential cardio-protective effect by increasing
blood HDL cholesterol levels and decreasing total chol-
esterol, triglyceride and LDL cholesterol levels in hyper-
lipidemic patients [19]. While the health benefits of S.
officinalis plant extract are relatively well established,
the effects of S. libanotica on glycemia and lipidemia
have not been fully elucidated. Moreover, most studies
on S. libanotica are short term studies [12], and have
been conducted on its essential oil rather than on water
extract [20–22]. In order to simulate human consump-
tion and folk medicine protocols which rely on herbal
infusions [14, 20–22], the present study was carried out
to assess the effect of chronic intake (6 weeks) of S.
libanotica water extract on glycemia and lipemia and
explore the associated mechanisms of action in healthy
rats fed a high-fat diet.
Methods
Plant material
S. libanotica plant was collected from different areas
throughout Lebanon between July and September 2013.
The plant was identified according to the characteristics
described in “Handbook of Medicinal Herbs” book [23].
Also, a voucher specimen of the plant material used has
been deposited at the herbarium of the Department of
Natural Sciences, Lebanese American University (refer-
ence number: SL-2-2013). Fresh plant material was col-
lected from wild bushes; leaves were separated and dried
in the shade at room temperature. The dried leaves
(130 g) were then chopped into small pieces and soaked
in 2 L pre-boiled water for 30 min for extraction. The
water extract was filtered and subjected to freeze drying
yielding 8.3 % w/w of dry material that was stored in re-
frigerated amber glass containers. This procedure was
repeated weekly throughout the study.
Animals
Adults Spargue-Dawley rats (Lebanese American
University Stock) weighing 180–240 g were housed in a
temperature and humidity-controlled room under a
12:12 light/dark cycle (lights on at 0800 h). Rats were
randomly allocated into four weight-matched groups of
ten rats each and were studied for 6 weeks. Animals
were fed ad libitum a standard chow diet to which 5 %
of coconut oil was added in order to increase the diet’s
atherogenicity (Table 1) [24]. The control group was
given water, and the other groups were given three dif-
ferent doses of S. libanotica in drinking water (GI:
50 mg/Kg body weight; GII: 150 mg/Kg body weight;
GIII: 450 mg/Kg body weight). All experimental proto-
cols were approved by the Animal Ethical subcommit-
tee of the Lebanese American University, which
complies with Guide for the Care and Use of Labora-
tory Animals [25].
Glucose tolerance test
On days 17 and 36 of the experiment, an ipGTT (in-
traperitoneal glucose tolerance test using intraperito-
neal injection of 300 g glucose/L in physiologic saline
in a dose of 5.83 mL/Kg boy weight) was performed
on rats that have been fasted for 3 h. After 45 min,
blood was collected from the animals’ tail vein and
assayed for glucose level.
Table 1 Nutrient composition of the high fat diet compared to
standard high carbohydrate (HC) diet
Standard HCa High Fatb
Protein (% wt) 19 18.1
Carbohydrates (%wt) 65.3 62.2
Sugars 9.2 8.8
Fat (% wt) 9.6 13.9
Fat breakdown
Saturated fat 18 % 21 %
Mono-unsaturated fat 29 % 28 %
Poly-unsaturated fat 47 % 45 %
Fiber (%wt) 4.3 4.1
Metabolizable energy (kJ/g) 17.7 18.7
Energy (Protein) 18 % 16 %
Energy (Carbohydrate) 62 % 56 %
Energy (Fat) 20 % 28 %
aLaboratory rodent starter diet no. 1, Hawa Chicken Co. (Safra, Lebanon)
bDiet derived from the standard HC diet enriched with coconut oil
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Metabolic profile
After 6 weeks, fasted rats (18 h) were anesthetized and
sacrificed after 18 h. Serum samples were isolated from
4 ml of venous blood which were drawn from the infer-
ior vena cava and stored at −80 °C for subsequent ana-
lysis. Serum glucose, lipids (total cholesterol, HDL
cholesterol, triglycerides) and liver enzyme activities of
aspartate transaminase (AST), alanine transaminase
(ALT) and alkaline phosphatase (ALP) were determined
using the relevant Spinreact kits (Spinreact, Spain). LDL
cholesterol was calculated using the Friedwald equation
(LDL = total cholesterol – HDL – (triglycerides/5)) [26].
Serum insulin was determined using Rat-insulin ELISA
kit (Merck Millipore,Germany). All serum samples were
run in duplicate and analyzed within the same assay. In
addition, following sacrifice, the intra-abdominal fat (epi-
didymal, mesenteric and retroperitoneal) was removed
from the animals, after which it was cleaned, blotted on
a filter paper and weighed.
Liver glycogen content
Rats’ livers were isolated, weighed, and then preserved
at −45 °C until testing. Hepatic glycogen was assayed
using 1 g of tissue according to the extraction method
mentioned by Hassid and Abraham [27]. Briefly, 1 g of
tissue was homogenized with 10 % trichloroacetic acid
solution and glycogen was precipitated using 95 % etha-
nol. After diluting it with distilled water, glycogen was
then determined colorimetrically by the anthrone
method.
In-vitro digestive enzymes inhibition assays
The effects of S. libanotica on the intestinal enzymes
alpha-amylase and alpha-glucosidase were determined
in-vitro [28, 29]. Solutions of plant extracts were pre-
pared at concentrations of 10, 20, 40, 60, 80 and
100 mg/dl. Controls were prepared by replacing the
plant extract with distilled water, and acarbose was used
as the positive control.
In-vitro alpha-amylase inhibition assay
For each concentration, 1 ml of the plant extract solu-
tion was mixed with 1 ml of 0.5 % starch solution and
1 ml of enzyme solution (0.5–1 unit/ml in 20 mM so-
dium phosphate buffer, pH:6.9), and the mixture was in-
cubated at 25 °C for 3 min. Afterwards, 1 ml of color
reagent was added. The latter was prepared by mixing
96 nM of 3,5 dinitrosalicylic acid (20 ml) with 5.31 M
sodium potassium tartrate in 2 M sodium hydroxide
(8 ml), all made up to 12 ml volume with deionized
water. The mixture was placed in closed tubes in a water
bath at 85 °C for 15 min. Tubes were then removed
from water bath, cooled and diluted with 9 ml of
distilled water and absorbance was read at 540 nm in a
spectrophotometer.
Iα−amylase% ¼ 100 x ∆AControl−∆ASample
 
= ∆Acontrolð Þ
Where ∆AControl = Atest − ABlank and ∆Asample = Atest
− ABlank
In-vitro alpha-glucosidase inhibition assay
Alpha-glucosidase reaction mixture was prepared by
adding 2.9 mM p-nitrophenyl- α-D-glucopyranoside
(pNPG) to 0.25 mL of each plant extract concentrations
and 0.6 U/ml α-glucosidase in sodium phosphate buffer
(pH 6.9). The reaction mixture was incubated at 25 °C for
5 min and then the reaction was stopped by boiling for
2 min. Absorbance of the resulting p-nitrophenol (pNP)
was determined at 405 nm using spectrophotometer.
% Glucosidase inhibition
¼ 100% −% activity of test as percentage of control
% activity of test
¼ Corrected A405 of test x 100% =A405 of controls
Statistical analysis
Data are reported as Mean ± SEM. Results were analyzed
by one-way analysis of variance (ANOVA). Significant
main effect differences were tested using Tukey–Kramer’s
post hoc test for multiple comparison. All data were ana-
lyzed with the statistical package SPSS 18 and statistical
significance was defined as p < 0.05.
Results and discussion
Results
Chronic intake of S. libanotica extract showed a trend
of weight loss in the majority of animals, with a sig-
nificant decrease in abdominal fat percent in GIII
(Table 2). Fasting serum glucose concentrations on
day 42 of the study were lower in the treated groups
compared to controls with the difference reaching
statistical significance at the two highest doses used
(Fig. 1a). Similarly, ipGTT on day 17 and day 36 of
the study showed significantly (p < 0.05) lower venous
blood glucose levels in GIII versus control group,
45 min after intrapertitoneal injection of glucose solu-
tion (Fig. 2). Additionally, the fasting serum insulin
concentrations were higher in the treated groups
compared to controls with significance (p < 0.05)
reached at the highest dose (Fig. 1b). Furthermore,
there was a dose dependent increase in liver glycogen
with significance (p < 0.05) reached in GII and GIII
(Fig. 1c).
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As for blood lipids, there was no significant difference
in serum total cholesterol, LDL-cholesterol (LDL) and
triglycerides among groups.
Conversely, plant treatment was associated with higher
fasting serum HDL-cholesterol (HDL) and HDL/LDL ra-
tio but the differences were only significant in GIII in
the former and in GII and GIII in the latter compared to
control group (Table 3).
Serum levels of AST and ALT in the different experi-
mental groups were similar to those of the control. On
the other hand, serum LDH levels in GII and GIII, but
not GI, were significantly lower than that of the control
group (Table 4). The dose dependent in vitro assay did
not show any effect of the different doses of the plant
extract, ranging from 10 to 100 mg/dl, on the intestinal
enzymes alpha-glucosidase and alpha-amylase.
Discussion
The objective of the current study was to investigate the
effect of chronic administration of S. libanotica water
extract on glycemia, serum lipid profile, food intake, and
abdominal fat of rats fed a high fat diet, as well as to ex-
plore potential mechanisms of action. The present work
is the first to simulate human consumption of S. libano-
tica by mimicking its usual consumption as herbal infu-
sion in the Middle East. Results showed a significant
Table 2 Body weight gain and abdominal fat after 6 weeks of S. libanotica intake
Control GI GII GIII
Body weight gain (g) 96.71± 5.31 76.33± 10.03 82.00± 5.84 71.20± 14.63
Abdominal fat (g) 2.96± 0.34 2.91± 0.37 2.61± 0.51 2.53± 0.41
Abdominal fat (%body weight) 0.78± 0.08 0.79± 0.10 0.74± 0.14 0.57± 0.06*
Data are presented as mean ± SEM, (n = 10). *corrected p-value≤ 0.05 vs. control using ANOVA and Tukey’s post-hoc test
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Fig. 1 Fasting serum glucose and insulin, and liver glycogen content. Fasting serum glucose (a), insulin (b) and liver glycogen (c) after 6 weeks of
S. libanotica intake. Data are presented as mean ± SEM, (n = 10). *corrected p-value≤ 0.05 vs. control using ANOVA and Tukey’s post-hoc test
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decrease in fasting blood glucose and an increase in
serum insulin and liver glycogen. Moreover, treatment
with plant extract was associated with improved lipid
profiles characterized by higher HDL-cholesterol and
HDL/LDL ratio, as well a decrease in abdominal fat
percent.
Although not significant, chronic intake of the plant
extract caused 15.2 to 26.4 % decrease in body weight
gain in animals receiving the extract compared to con-
trol group. A similar decrease in abdominal fat ranging
between 1.6 to 14.5 % of the animals was also observed.
Moreover, calculation of the abdominal fat/body weight
ratio showed a significant decrease in group III com-
pared to control animals, suggesting a potential benefit
of plant intake on abdominal fat deposition.
High fat diet administration for 6 weeks induced fast-
ing hyperglycemia (152.1 ± 7.9 mg/dl) in the control
group, while treatment with S. libanotica normalized
fasting glucose at the two higher doses used (150 and
450 mg/Kg body weight). This appeared to be mediated
by an insulinotropic effect of the plant water extract,
which was demonstrated through the dose dependent
increase in fasting serum insulin level. Therefore, we
suggest that the plant treatment triggered more insulin
secretion which might have increased glucose uptake by
the tissues and thus lowered serum glycemia. This is in
line with the higher liver glycogen content observed,
which is also an indication of improved hepatic insulin
sensitivity [30]. Such mechanism is supported by the in-
vitro assessment of alpha-glucosidase and alpha-amylase
activities, which did not reveal any inhibitory effect of S.
libanotica water extract on these carbohydrate-digesting
enzymes.
The plant hypoglycemic effect was also evident in the
glucose tolerance test (ipGTT), whereby plant treatment
at the dose of 450 mg/kg body weight (GIII) was associ-
ated with significantly lower glycemia, 45 min following
an intrapertitoneal injection of glucose solution. This
0
40
80
120
160
200
Control GI GII GIII
IP Glucose Tolerance Test
m
g/
dl
* *
Fig. 2 Glucose tolerance test. Serum glucose, 45 min after intraperitoneal injection of glucose solution (ipGTT) on days 17 (clear bars) and 36
(dashed bars) of the experiment. Data are presented as mean ± SEM, (n = 10). *corrected p-value≤ 0.05 vs. control using ANOVA and Tukey’s
post-hoc test
Table 3 Fasting serum triglycerides, total cholesterol, LDL-cholesterol (LDL), HDL-cholesterol (HDL) and HDL/LDL ratio after 6 weeks
of S. libanotica intake
Control GI GII GIII
Triglycerides (mg/dl) 37.9± 1.7 39.8± 2.1 35.4± 4.8 38.3± 4.2
Total Cholesterol (mg/dl) 49.8± 2.8 50.2± 3.3 51.4± 4.8 54.5± 3.1
LDL Cholesterol (mg/dl) 15.6± 2.3 15.1± 3.0 11.2± 3.3 11.4± 3.2
HDL Cholesterol (mg/dl) 27.2± 1.9 27.4± 2.5 31.2± 2.6 34.4± 2.4*
HDL/LDL ratio 1.74± 0.18 1.81± 0.25 2.79± 0.32* 3.02± 0.31*
Data are presented as mean ± SEM, (n = 10). *corrected p-value≤ 0.05 vs. control using ANOVA and Tukey’s post-hoc test
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effect was even significant only after 17 days of plant
treatment. This improved glucose tolerance could be the
result of higher insulin response or increased insulin
sensitivity, however none of these parameters was mea-
sured and thus further investigations are needed. Previ-
ous work by Perfumi et al. [14] showed lower blood
glucose levels after an oral glucose load in normogly-
cemic and alloxan-induced hyperglycemic rabbits that
were given a single oral dose of S. fruticosa infusion (at
250 mg dry leaves/kg body weight); however, no
hypoglycemic effect was found after repeated adminis-
tration of the infusion for seven days in normoglycemic
rabbits. Moreover, the latter study did not find an effect
of the plant extract on fasting or glucose-stimulated in-
sulin levels. The discrepancy between the present results
and those of Perfumi et al. [14] could be due to the dif-
ferences in animal models used (rabbits vs. rats), mode
of plant extract administration (single daily oral dose vs.
drinking water) and study duration (7d vs. 42d). More-
over, based on the extract yield obtained from the
current study, the dose used in Perfumi’s study would be
about 21 mg water extract/kg bodyweight, which is sub-
stantially lower than the doses used in the present work.
The chronic intake of S. libanotica water extract sig-
nificantly increased HDL cholesterol (group III) levels
and HDL/LDL ratio (group II and III). The latter was
found to be a strong marker of atherosclerosis com-
pared to LDL and HDL alone [31], thereby suggesting a
cardioprotective potential of the plant. To the best of
our knowledge, this study is the first to demonstrate
the dual hypolipidemic and hypoglycemic effect of the
chronic intake of the plant extract. Both effects were
not associated with toxicity since there was no eleva-
tion in serum activities of ALT and AST after 6 weeks
of supplementation with the extract. Results also
showed that LDH levels were significantly reduced in
Group II and III, indicating the absence of pathological
damage, as LDH is an enzyme that is found in almost
all body cells and is released upon cell damage and de-
struction. Additionally, plant safety was further con-
firmed in our lab when a separate group of rats
survived incremental oral doses of the plant extract
reaching 8000 mg/Kg body weight.
Conclusions
The present study demonstrated the first evidence of the
hypoglycemic and hypolipidemic effect of the chronic in-
take of S. Libanotica water extract in healthy rats, and
proved to be safe throughout the study. Therefore, the
results suggest a promising role of S. Libanotica water
extract in the prevention of chronic diseases such as dia-
betes, and cardiovascular diseases, with low cost and
without compromising safety. Future studies are war-
ranted to further explore mechanisms of action and to
fractionate and purify the plant extract in order to iden-
tify the active ingredient(s) responsible for the observed
beneficial effects.
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